BRPI0917993A2 - composições de célula-tronco mesenquimal purificada e métodos de purificação de composições de célula-tronco mesenquimal purificda. - Google Patents

composições de célula-tronco mesenquimal purificada e métodos de purificação de composições de célula-tronco mesenquimal purificda.

Info

Publication number
BRPI0917993A2
BRPI0917993A2 BRPI0917993A BRPI0917993A BRPI0917993A2 BR PI0917993 A2 BRPI0917993 A2 BR PI0917993A2 BR PI0917993 A BRPI0917993 A BR PI0917993A BR PI0917993 A BRPI0917993 A BR PI0917993A BR PI0917993 A2 BRPI0917993 A2 BR PI0917993A2
Authority
BR
Brazil
Prior art keywords
stem cell
mesenchymal stem
cell compositions
purified mesenchymal
purification
Prior art date
Application number
BRPI0917993A
Other languages
English (en)
Inventor
Danilkovich Alla
Ton Christopher
Young Randal
e newman Robert
Tom Samson
Wang Zhanling
Original Assignee
Osiris Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41669330&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0917993(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Osiris Therapeutics Inc filed Critical Osiris Therapeutics Inc
Publication of BRPI0917993A2 publication Critical patent/BRPI0917993A2/pt
Publication of BRPI0917993B1 publication Critical patent/BRPI0917993B1/pt
Publication of BRPI0917993B8 publication Critical patent/BRPI0917993B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Microbiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
BRPI0917993A 2008-08-14 2009-08-14 composições de célula-tronco mesenquimal purificada BRPI0917993B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8889808P 2008-08-14 2008-08-14
US61/088,898 2008-08-14
PCT/US2009/053891 WO2010019886A1 (en) 2008-08-14 2009-08-14 Purified mesenchymal stem cell compositions and methods of purifying mesenchymal stem cell compositions

Publications (3)

Publication Number Publication Date
BRPI0917993A2 true BRPI0917993A2 (pt) 2017-10-10
BRPI0917993B1 BRPI0917993B1 (pt) 2020-12-29
BRPI0917993B8 BRPI0917993B8 (pt) 2021-05-25

Family

ID=41669330

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0917993A BRPI0917993B8 (pt) 2008-08-14 2009-08-14 composições de célula-tronco mesenquimal purificada

Country Status (14)

Country Link
US (5) US8637004B2 (pt)
EP (2) EP2318519B1 (pt)
JP (6) JP6025329B2 (pt)
AR (2) AR073069A1 (pt)
AU (1) AU2009281809B2 (pt)
BR (1) BRPI0917993B8 (pt)
CA (1) CA2733985C (pt)
DK (1) DK2318519T3 (pt)
ES (1) ES2608974T3 (pt)
IL (1) IL211214A0 (pt)
MX (2) MX362512B (pt)
NZ (2) NZ591146A (pt)
WO (1) WO2010019886A1 (pt)
ZA (1) ZA201101858B (pt)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2298862B1 (en) 2004-03-22 2017-08-30 Mesoblast International Sàrl Mesenchymal stem cells and uses therefor
WO2007087139A2 (en) 2006-01-13 2007-08-02 Osiris Therapeutics, Inc. MESENCHYMAL STEM CELLS EXPRESSING TNF-α RECEPTOR
NZ591146A (en) 2008-08-14 2012-10-26 Osiris Therapeutics Inc Composition comprising mesenchymal stem cell aggregates wherein the D90 of said aggregates is less than 150 micomills
EP3539380A3 (en) 2008-08-20 2019-12-18 Celularity, Inc. Improved cell composition and methods of making the same
US9192695B2 (en) 2008-11-20 2015-11-24 Allosource Allografts combined with tissue derived stem cells for bone healing
EP2624845A4 (en) * 2010-10-08 2015-09-09 Mesoblast Internat S Rl REINFORCED MSC PREPARATIONS
WO2012048298A2 (en) 2010-10-08 2012-04-12 Caridianbct, Inc. Methods and systems of growing and harvesting cells in a hollow fiber bioreactor system with control conditions
ITGE20120034A1 (it) * 2012-03-28 2013-09-29 Carlo Tremolada Preparato e metodo per la produzione di un preparato comprendente cellule staminali mesenchimali
JP2013252126A (ja) * 2012-05-08 2013-12-19 Otsuka Pharmaceut Factory Inc デキストラン含有肺塞栓形成予防用哺乳動物細胞懸濁液
EP2970882B1 (en) 2013-03-15 2018-11-28 AlloSource Cell repopulated collagen matrix for soft tissue repair and regeneration
WO2015073913A1 (en) 2013-11-16 2015-05-21 Terumo Bct, Inc. Expanding cells in a bioreactor
US11008547B2 (en) 2014-03-25 2021-05-18 Terumo Bct, Inc. Passive replacement of media
CN106715676A (zh) 2014-09-26 2017-05-24 泰尔茂比司特公司 按计划供养
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
EP3238759B1 (en) 2016-04-29 2019-07-17 Fenwal, Inc. System and method for processing, incubating and/or selecting biological cells
EP3238760B1 (en) * 2016-04-29 2019-10-02 Fenwal, Inc. System and method for selecting and culturing cells
CN109415696A (zh) 2016-05-25 2019-03-01 泰尔茂比司特公司 细胞扩增
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
US10274495B2 (en) 2016-12-21 2019-04-30 Fenwal, Inc. System and method for separating cells incorporating magnetic separation
EP3601521A2 (en) 2017-03-31 2020-02-05 Terumo BCT, Inc. Cell expansion
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
EP3847241A1 (en) * 2018-10-26 2021-07-14 Stemselect Method and apparatus for mesenchymal stem cells isolation and purification
WO2020231968A1 (en) * 2019-05-15 2020-11-19 Stemcyte Inc. High concentration cell packaging and shipping
WO2021144995A1 (ja) * 2020-01-16 2021-07-22 ＰｕＲＥＣ株式会社 高純度間葉系幹細胞

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5034135A (en) * 1982-12-13 1991-07-23 William F. McLaughlin Blood fractionation system and method
US4803075A (en) * 1986-06-25 1989-02-07 Collagen Corporation Injectable implant composition having improved intrudability
JP2881305B2 (ja) 1986-08-11 1999-04-12 バクスター、インターナショナル、インコーポレイテッド 血球洗浄システムおよび方法
US5536475A (en) * 1988-10-11 1996-07-16 Baxter International Inc. Apparatus for magnetic cell separation
US5837539A (en) 1990-11-16 1998-11-17 Osiris Therapeutics, Inc. Monoclonal antibodies for human mesenchymal stem cells
US5226914A (en) 1990-11-16 1993-07-13 Caplan Arnold I Method for treating connective tissue disorders
US5197985A (en) 1990-11-16 1993-03-30 Caplan Arnold I Method for enhancing the implantation and differentiation of marrow-derived mesenchymal cells
US5486359A (en) 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
US5234608A (en) 1990-12-11 1993-08-10 Baxter International Inc. Systems and methods for processing cellular rich suspensions
ES2206509T3 (es) * 1994-06-06 2004-05-16 Case Western Reserve University Biomatriz para la regeneracion de tejidos.
US5707996A (en) * 1995-11-06 1998-01-13 Macleod Pharmaceuticals, Inc. Pharmaceutical solution and methods for preparation thereof
CA2251983C (en) * 1996-04-19 2003-12-16 Sudhakar Kadiyala Regeneration and augmentation of bone using mesenchymal stem cells
US5827740A (en) * 1996-07-30 1998-10-27 Osiris Therapeutics, Inc. Adipogenic differentiation of human mesenchymal stem cells
WO1999003973A1 (en) * 1997-07-14 1999-01-28 Osiris Therapeutics, Inc. Cardiac muscle regeneration using mesenchymal stem cells
US6251295B1 (en) 1998-01-08 2001-06-26 Nexell Therapeutics Inc. Method for recirculation washing of blood cells
WO1999047163A2 (en) 1998-03-18 1999-09-23 Osiris Therapeutics, Inc. Mesenchymal stem cells for prevention and treatment of immune responses in transplantation
FR2787463B1 (fr) 1998-12-21 2001-03-30 Neurotech Preparation de cellules de mammifere eventuellement transfectees avec un gene codant pour une substance active et les compositions les contenant
JP2002325572A (ja) * 2000-12-25 2002-11-12 Univ Osaka 外来物質の導入方法
US20030054331A1 (en) 2001-09-14 2003-03-20 Stemsource, Inc. Preservation of non embryonic cells from non hematopoietic tissues
US8404229B2 (en) * 2001-12-07 2013-03-26 Cytori Therapeutics, Inc. Methods of using adipose derived stem cells to treat acute tubular necrosis
US7585670B2 (en) * 2001-12-07 2009-09-08 Cytori Therapeutics, Inc. Automated methods for isolating and using clinically safe adipose derived regenerative cells
US7514075B2 (en) * 2001-12-07 2009-04-07 Cytori Therapeutics, Inc. Systems and methods for separating and concentrating adipose derived stem cells from tissue
JP4653952B2 (ja) * 2001-12-07 2011-03-16 サイトリ セラピューティクス インコーポレイテッド 処理済み脂肪吸引細胞で患者を治療するためのシステムと方法
US20050008626A1 (en) 2001-12-07 2005-01-13 Fraser John K. Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
US20050048036A1 (en) * 2001-12-07 2005-03-03 Hedrick Marc H. Methods of using regenerative cells in the treatment of inherited and acquired disorders of the bone, bone marrow, liver, and other tissues
US9597395B2 (en) * 2001-12-07 2017-03-21 Cytori Therapeutics, Inc. Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
US8105580B2 (en) * 2001-12-07 2012-01-31 Cytori Therapeutics, Inc. Methods of using adipose derived stem cells to promote wound healing
US20050095228A1 (en) * 2001-12-07 2005-05-05 Fraser John K. Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders
ZA200404101B (en) 2003-05-26 2005-03-07 Reliance Life Sciences Pvt Ltd In vitro culture of Mesenchymal Stem Cells (MSC) and a process for the preparation thereof for therapeutic use.
WO2005012480A2 (en) 2003-06-25 2005-02-10 Macropore Biosurgery Inc. Systems and methods for separating and concentrating regenerative cells from tissue
EP2298862B1 (en) 2004-03-22 2017-08-30 Mesoblast International Sàrl Mesenchymal stem cells and uses therefor
JP3828905B2 (ja) * 2004-08-05 2006-10-04 株式会社Ｒ＆Ｄセルサイエンス・オプショナルメディコ 局所麻酔薬を含有する細胞凝集抑制剤
WO2006135854A2 (en) * 2005-06-10 2006-12-21 Board Of Regents, The University Of Texas System Antiseptic compositions
CA2663749A1 (en) 2005-09-21 2007-03-29 Dask Technologies, Llc Methods and compositions for organ and tissue functionality
US7888119B2 (en) * 2005-10-14 2011-02-15 University Of Central Florida Research Foundation, Inc. Tissue substitutes comprising stem cells and reduced ceria
US20070253931A1 (en) * 2006-01-12 2007-11-01 Osiris Therapeutics, Inc. Use of mesenchymal stem cells for treating genetic diseases and disorders
AU2007209870A1 (en) 2006-01-30 2007-08-09 University Of Virginia Patent Foundation Methods of preparing and characterizing mesenchymal stem cell aggregates and uses thereof
CN101448527B (zh) 2006-05-19 2013-12-18 香港大学 细胞-基质微球，制备方法和应用
KR20090043559A (ko) 2006-08-15 2009-05-06 에이전시 포 사이언스, 테크놀로지 앤드 리서치 중간엽 줄기세포 조절배지
CA2913024A1 (en) * 2006-11-03 2008-05-08 Aastrom Biosciences, Inc. Mixed cell populations for tissue repair and separation technique for cell processing
JP2008139106A (ja) * 2006-11-30 2008-06-19 Sysmex Corp 骨髄穿刺液収容具及び骨髄穿刺液濾過方法
WO2008073331A2 (en) 2006-12-07 2008-06-19 Teva Pharmaceutical Industries Ltd. Method of generation and expansion of tissue-progenitor cells and mature tissue cells from intact bone marrow or intact umbilical cord tissue
US20110262402A1 (en) 2007-09-07 2011-10-27 Masahiko Kuroda Therapeutic and prophylactic agents for arthritis
EP2210608B1 (en) 2007-11-02 2016-08-31 JCR Pharmaceuticals CO., LTD. Pharmaceutical composition containing human mesenchymal stem cell
NZ591146A (en) 2008-08-14 2012-10-26 Osiris Therapeutics Inc Composition comprising mesenchymal stem cell aggregates wherein the D90 of said aggregates is less than 150 micomills
US8217128B2 (en) 2008-09-04 2012-07-10 Amyris, Inc. Farnesene interpolymers

Also Published As

Publication number Publication date
BRPI0917993B1 (pt) 2020-12-29
JP2017081972A (ja) 2017-05-18
IL211214A0 (en) 2011-04-28
JP2020120671A (ja) 2020-08-13
WO2010019886A1 (en) 2010-02-18
JP2018109052A (ja) 2018-07-12
JP6025329B2 (ja) 2016-11-16
CA2733985A1 (en) 2010-02-18
AU2009281809A1 (en) 2010-02-18
EP2318519A1 (en) 2011-05-11
AU2009281809B2 (en) 2015-09-17
BRPI0917993B8 (pt) 2021-05-25
JP2012500214A (ja) 2012-01-05
US8637004B2 (en) 2014-01-28
MX2011001730A (es) 2011-03-24
NZ591146A (en) 2012-10-26
MX362512B (es) 2019-01-22
ZA201101858B (en) 2011-11-30
JP2023052211A (ja) 2023-04-11
AR073069A1 (es) 2010-10-13
US20140105872A1 (en) 2014-04-17
EP2318519A4 (en) 2013-07-24
EP3124601A1 (en) 2017-02-01
US20100068191A1 (en) 2010-03-18
CA2733985C (en) 2016-07-12
US20200197444A1 (en) 2020-06-25
US20180008642A1 (en) 2018-01-11
EP2318519B1 (en) 2016-10-05
JP2015071610A (ja) 2015-04-16
DK2318519T3 (en) 2017-01-16
US20230089901A1 (en) 2023-03-23
AR123811A2 (es) 2023-01-18
ES2608974T3 (es) 2017-04-17
NZ602248A (en) 2014-03-28

Similar Documents

Publication Publication Date Title
BRPI0917993A2 (pt) composições de célula-tronco mesenquimal purificada e métodos de purificação de composições de célula-tronco mesenquimal purificda.
DK2620493T3 (da) Mesenkymale stamceller til behandling af CNS-sygdomme
SE0950586L (sv) Förbättrad odling av stamceller
BRPI0813787A2 (pt) Cultura de célula-tronco pluripotente isolada
GB0814249D0 (en) Uses of mesenchymal stem cells
BRPI0922084A2 (pt) Composições e métodos compreendendo variantes de serina protease
BRPI1011933A2 (pt) composição de purificação de gás ácido
DK2574677T3 (da) Fremgangsmåder til celledyrkning
DE602008000052D1 (de) Wasserreinigungszusammensetzung
BRPI0919237A2 (pt) purificação de policarbonatos
BRPI0907170A2 (pt) planta de purificação de gás de combustão
BRPI1009447A2 (pt) métodos de purificação de proteínas imunofarmacêuticas modulares pequenas
SI2398785T1 (sl) Äśiĺ äśenje 1-(2-(2,4-dimetilfenilsulfanil)fenil)-piperazina
BRPI0912874A2 (pt) purificação de dióxido de carbono
BRPI0908237A2 (pt) Pequenos grânulos contendo enzima
BRPI0913925A2 (pt) Diferenciação de células-tronco pluripotentes
BR112012003148A2 (pt) composição de remoção de oxigênio, artigo,e, uso da composição de remoção de oxigênio
BRPI0915394A2 (pt) purificação de citoquinas modificadas
BR112012003152A2 (pt) composição removedora de oxigênio, artigo,e, uso de composição removedora de oxigênio.
DE112009001953T8 (de) Siliziumreinigungsverfahren
BRPI0910691A2 (pt) compostos e composições como inibidores de itpkb
BR112012008053A2 (pt) fermentação purificação de heparosano k5.
BRPI0922716A2 (pt) purificação de polipeptídeo
BRPI1006685A2 (pt) composição de redução da dureza da água
BRPI0920524A2 (pt) método de purificação

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: MESOBLAST INTERNATIONAL SARL (CH)

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 29/12/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 14/08/2009 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF